Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.2 INR | -0.65% | +1.80% | +3.96% |
Apr. 18 | Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3% | MT |
Apr. 02 | Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment | MT |
Sales 2022 | 782M 9.39M | Sales 2023 | 1.27B 15.27M | Capitalization | 15.22B 183M |
---|---|---|---|---|---|
Net income 2022 | 2.22B 26.65M | Net income 2023 | 1.91B 22.87M | EV / Sales 2022 | 23.4 x |
Net cash position 2022 | 270M 3.25M | Net cash position 2023 | 464M 5.56M | EV / Sales 2023 | 11.6 x |
P/E ratio 2022 |
8.37
x | P/E ratio 2023 |
7.99
x | Employees | 271 |
Yield 2022 |
2.49% | Yield 2023 |
3.71% | Free-Float | 27.91% |
1 day | -0.65% | ||
1 week | +1.80% | ||
Current month | +12.60% | ||
1 month | +16.64% | ||
3 months | +2.00% | ||
6 months | +18.74% | ||
Current year | +3.96% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 69 | 88-07-01 | |
Rasesh J. Shah
DFI | Director of Finance/CFO | - | 14-08-12 |
Chairman | 76 | 67-08-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 67-08-19 | |
Chief Executive Officer | 69 | 88-07-01 | |
Director/Board Member | 44 | 13-04-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 94.2 | -0.65% | 150 736 |
24-04-25 | 94.82 | -0.87% | 25,415 |
24-04-24 | 95.65 | +2.08% | 34,995 |
24-04-23 | 93.7 | +1.78% | 71,333 |
24-04-22 | 92.06 | -0.51% | 31,901 |
Delayed Quote Bombay S.E., April 26, 2024 at 06:24 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+3.96% | 292M | |
+36.16% | 27.29B | |
-13.74% | 26.65B | |
+25.00% | 26.56B | |
+44.49% | 22.46B | |
-0.71% | 23.73B | |
+2.78% | 19.61B | |
+1.45% | 18.04B | |
+28.54% | 16.12B | |
+17.00% | 14.48B |
- Stock Market
- Equities
- ALEMBICLTD Stock